Change over period: —
NSE · PFIZER
PFIZER LTD.
-26.1% from the 52-week high · +6.4% above the low
Pfizer Ltd. engages in the business of manufacturing, marketing, trading, import and export of pharmaceutical products. The company is headquartered in Mumbai, Maharashtra and currently employs 1,702 full-time employees. The firm is engaged in manufacturing, marketing, trading and export of pharmaceutical products. The firm has its own manufacturing facility at Goa. The firm has various independent contract/third party manufacturers based across India. Its product portfolio includes vaccine, anti-infectives, cardiac, pain, maternal nutrition, gastrointestinal, contraceptives, anti-inflammatory, nutrition and immunity, and respiratory. The firm's vaccine business is focused on Prevenar 13, a pneumococcal conjugate vaccine that is administered to infants who are six weeks and older as part of primary vaccination, toddlers, adolescents, adults, and elderly population. Its inflammation and immunology portfolio includes two advanced therapies, which cater to patients suffering from diseases related to chronic immune system such as rheumatoid arthritis, ankylosing spondylitis, juvenile idiopathic arthritis, psoriasis and ulcerative colitis.
The short version. Promoter holding was 63.92% in Sep 2026, up 0.00 points over 8 quarters.
1 · The price
How has the stock traded?
PFIZER LTD. trades 26.1% below its 52-week high and 6.4% above its 52-week low.
4 · The owners
Who holds it, and are they adding?
Unchanged over 8 quarters.
Down 1.12 pts over 8 quarters.
Up 0.73 pts over 8 quarters.
+4 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 63.92 | 63.92 | 63.92 | 63.92 | 63.92 | 63.92 | 63.92 | 63.92 | 0.0 |
| FII | 2.75 | 2.18 | 2.39 | 2.6 | 2.71 | 2.81 | 1.65 | 1.63 | -1.12 |
| DII | 16.79 | 17.1 | 17.23 | 17.1 | 17.05 | 16.89 | 17.8 | 17.52 | +0.73 |
| Public | 16.54 | 16.79 | 16.45 | 16.37 | 16.32 | 16.37 | 16.63 | 16.92 | +0.38 |
Mutual fund holdings · Oct 2026
41 schemes hold this stock
37 the month before.
- quant Healthcare Fund7.14% of NAV
- NJ ELSS Tax Saver Fund2.69% of NAV
- DSP Healthcare Fund2.61% of NAV
- TATA INDIA PHARMA & HEALTHCARE FUND2.4% of NAV
- ICICI Prudential Healthcare Fund2.33% of NAV
- quant Small Cap Fund1.77% of NAV
- ADITYA BIRLA SUN LIFE MNC FUND1.67% of NAV
- Bandhan Healthcare Fund1.47% of NAV
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for PFIZER LTD. are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Pharmaceuticals & Biotechnology stocks
Quick answers
Common questions about PFIZER LTD.
What is the PFIZER LTD. share price?
PFIZER LTD. (PFIZER) last closed at ₹3,850.30, up 0.22% on the day. Its 52-week range is ₹3,612.30 to ₹5,197.80.
What is the market cap of PFIZER LTD.?
PFIZER LTD. has a market capitalisation of about ₹17,589 crore. Its price-to-earnings ratio is 20.6.
How are PFIZER LTD.'s latest results?
Promoter holding was 63.92% in Sep 2026, up 0.00 points over 8 quarters.
Who owns PFIZER LTD.?
As of Sep 2026, shareholding was: Promoter 63.92%, FII 1.63%, DII 17.52%, Public 16.92%.
How many mutual funds hold PFIZER LTD.?
41 mutual fund schemes held PFIZER LTD. in October 2026. That compares with 37 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 09 Jul 2025 · Special Dividend - Rs. 130
- 09 Jul 2025 · Final Dividend - Rs. 35
- 21 Aug 2024 · Final Dividend - Rs. 35
- 11 Aug 2023 · Final Dividend - Rs. 35
- 11 Aug 2023 · Special Dividend - Rs. 5
- 19 Sep 2022 · Special Dividend - Rs. 30
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.